Educational overview of 7-hydroxymitragynine (7-OH), kratom withdrawal, and when buprenorphine-based treatment such as Suboxone may be considered. Covers opioid-like withdrawal symptoms, timing concerns, medical detox, kratom dependence, and clinical evidence for supervised treatment. Includes related resources on 7-OH withdrawal, kratom and Suboxone, and safe recovery support.

Educational overview of kratom addiction and severe withdrawal emerging in Long Island and New York, detailing 7-OH risks, FDA and local laws, and safe pathways to treatment.

In recent years, the rise of 7-hydroxymitragynine (7-OH) — one of the most potent alkaloids found in kratom — has raised serious concerns across New York State. While kratom is often marketed as a “natural” supplement, research shows that 7-OH has powerful opioid-like effects, leading to dependence, withdrawal, and even overdose when misused.

 

 

Why Accessibility Is a Public Health Issue

 

 

New York lawmakers are beginning to respond to this growing threat. In 2025, Senate Bill S7379 was introduced, proposing to add kratom to the list of Schedule I controlled substances under state law...